<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0104">Although promising, these new potential biomarkers may be unreliable on their own and will need to be combined with others to assess HBV cure. A significant challenge in the field is understanding which combinations are most informative. Studies addressing this question are often hampered by a relatively small number of patients who have achieved functional cure on current treatment regimens.</p>
